IP Library Granted Patent US 8,501,956
Granted Patent B2
US 8,501,956 · App. 13/229,491 · Granted Aug 6, 2013

Benzimidazole compounds

Inventors: John Demattei (Berthoud, CO); Sagar Shakya (San Diego, CA); Anthony D. Piscopio (Longmont, CO); Bruno P. Hache (Boulder, CO); Matthew Charles Evans (MacclesField, GB); James Gair Ford (Macclesfield, GB); Simon Mark Pointon (Macclesfield, GB); Koen Peeters (Wetteren, BE); Timothy John Lilley (Macclesfield, GB); John Leonard (Macclesfield, GB)
Assignees: Array BioPharma Inc.; AstraZeneca SB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,501,956
App. No.
13/229,491
Granted
Aug 6, 2013
Kind
B2
Abstract

Provided are compounds having Formula VIIIa-1: wherein Z, X 5 , R 2 , R 2a and R 10 are as defined herein. Compounds of Formula VIIIa-1 can be used to prepare heterocyclic derivatives such as benzimidazole derivatives.

Claims (13)

1. A compound having the Formula VIIIa-1

and salts and solvates thereof, wherein

Z is —C(═O)OR 1 , —C(═O)NR 6 R 7 , —C(═O)H, or

R 1 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, trialkylsilyl, or dialkylarylsilyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl and C 3 -C 6 heterocycloalkyl;

R 2 and R 2a are independently hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, benzyl, allyl, arylalkyl, trialkylsilyl, dialkylarylsilyl, —COR 6 , —C(O)OR 6 or —C(O)NR 6 R 7 , wherein said alkyl, alkenyl, alkynyl, benzyl, allyl and arylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, and C 2 -C 4 alkynyl;

X 5 is, F, Cl, Br, I or C 1 -C 6 alkyl;

R 6 and R 7 are independently hydrogen, trifluoromethyl, —OR 8 , C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl,

or R 6 and R 7 together with the atom to which they are attached form a 4 to 10 membered heteroaryl or heterocyclic ring, wherein said heteroaryl and heterocyclic rings are optionally substituted with one or more groups independently selected from halogen, trifluoromethyl, difluoromethoxy, trifluoromethoxy and OR 8 ;

R 8 is hydrogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, aryl or arylalkyl, wherein said alkyl, alkenyl, aryl and arylalkyl are optionally substituted with one or more groups independently selected from OH,  O—(C 1 -C 10 -alkyl) and —O—(C 1 -C 10 -alkenyl); and

R 10 is C 1 -C 10 alkyl, C 3 -C 10 cycloalkylalkyl, arylalkyl, heteroarylalkyl or heterocyclylalkyl, wherein said alkyl, cycloalkylalkyl, arylalkyl, heteroarylalkyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from halogen, hydroxyl, cyano, nitro, azido, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocycloalkyl, —NR 6 R 7 and —OR 8 .

2. The compound of claim 1 , wherein Z is —C(═O)NR 6 R 7 , wherein R 6 is —OR 8 , R 7 is H and R 8 is —(CH 2 ) 2 —OH.

3. The compound of claim 1 , wherein Z is —COOR 1 and R 1 is C 1-10 alkyl.

4. The compound of claim 3 , wherein R 1 is methyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2025
From: ASTRAZENECA AB
To: ALEXION PHARMA INTERNATIONAL OPERATIONS LIMITED
Reel/Frame 072888/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2011
From: DEMATTEI, JOHN; SHAKYA, SAGAR; PISCOPIO, ANTHONY D.; HACHE, BRUNO P.
To: ARRAY BIOPHARMA, INC.
Reel/Frame 027099/0348 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2011
From: EVANS, MATTHEW CHARLES; FORD, JAMES GAIR; POINTON, SIMON MARK; PEETERS, KOEN; LILLEY, TIMOTHY JOHN; LEONARD, JOHN
To: ASTRAZENECA AB
Reel/Frame 027099/0450 →
Continuity (3)
Division 11993745
Provisional Application 60693270 · Jun 23, 2005
Related Publication 20110319632A1 · Dec 29, 2011